000 01524 a2200433 4500
005 20250511182911.0
264 0 _c19921030
008 199210s 0 0 eng d
022 _a0732-183X
024 7 _a10.1200/JCO.1992.10.10.1569
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aMansi, J
245 0 0 _aHigh-dose busulfan in patients with myeloma.
_h[electronic resource]
260 _bJournal of clinical oncology : official journal of the American Society of Clinical Oncology
_cOct 1992
300 _a1569-73 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAdult
650 0 4 _aBone Marrow Transplantation
650 0 4 _aBusulfan
_xadministration & dosage
650 0 4 _aCombined Modality Therapy
650 0 4 _aCreatinine
_xblood
650 0 4 _aFemale
650 0 4 _aHematologic Diseases
_xchemically induced
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMelphalan
_xtherapeutic use
650 0 4 _aMiddle Aged
650 0 4 _aMultiple Myeloma
_xblood
650 0 4 _aPilot Projects
650 0 4 _aRemission Induction
650 0 4 _aTransplantation, Autologous
700 1 _ada Costa, F
700 1 _aViner, C
700 1 _aJudson, I
700 1 _aGore, M
700 1 _aCunningham, D
773 0 _tJournal of clinical oncology : official journal of the American Society of Clinical Oncology
_gvol. 10
_gno. 10
_gp. 1569-73
856 4 0 _uhttps://doi.org/10.1200/JCO.1992.10.10.1569
_zAvailable from publisher's website
999 _c1409528
_d1409528